Omeros Corporation
OMER
#6443
Rank
ยฃ0.57 B
Marketcap
ยฃ8.14
Share price
-1.63%
Change (1 day)
-6.38%
Change (1 year)

Omeros Corporation (OMER) - Cash on Hand

Cash on Hand as of June 2025 : ยฃ21.57 Million

According to Omeros Corporation's latest financial reports the company has ยฃ21.57 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Omeros Corporation - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ71.82 M-46.75%
2023-12-31ยฃ0.13 B-16.28%
2022-12-31ยฃ0.16 B38.29%
2021-12-31ยฃ0.11 B17.68%
2020-12-31ยฃ99 M113.58%
2019-12-31ยฃ46.35 M-2.73%
2018-12-31ยฃ47.66 M-23.09%
2017-12-31ยฃ61.96 M68.67%
2016-12-31ยฃ36.73 M92.63%
2015-12-31ยฃ19.07 M331.21%
2014-12-31ยฃ4.42 M-48.26%
2013-12-31ยฃ8.54 M-38.18%
2012-12-31ยฃ13.82 M-12.52%
2011-12-31ยฃ15.8 M-41.89%
2010-12-31ยฃ27.2 M-27.01%
2009-12-31ยฃ37.26 M173.34%
2008-12-31ยฃ13.63 M12.47%
2007-12-31ยฃ12.12 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
ยฃ2.28 M-89.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
ยฃ0.51 M-97.62%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
ยฃ11.24 B 52,029.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ13.93 B 64,476.96%๐Ÿ‡บ๐Ÿ‡ธ USA